Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00052416. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT06291220. IPD Sharing: NO. Countries: 5. Publications: 0.
Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00286780. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00086203. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00951457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02629809. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT06544785. IPD Sharing: NO. Countries: 1. Publications: 0.
Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02110394. IPD Sharing: Not stated. Countries: 1. Publications: 0.
506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
ClinicalTrials.gov study NCT00003635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Heavy Light Chain in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02377869. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01185262. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03755154. IPD Sharing: YES. Countries: 4. Publications: 0.
Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00646165. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04540796. IPD Sharing: YES. Countries: 8. Publications: 0.
Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT04169737. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00162851. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02619604. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
ClinicalTrials.gov study NCT01144260. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00868413. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients
ClinicalTrials.gov study NCT00058656. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.